Cargando…
Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028620/ https://www.ncbi.nlm.nih.gov/pubmed/36960320 http://dx.doi.org/10.1177/17588359231156383 |
| _version_ | 1784909984018989056 |
|---|---|
| author | Sorscher, Steven |
| author_facet | Sorscher, Steven |
| author_sort | Sorscher, Steven |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10028620 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100286202023-03-22 Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis Sorscher, Steven Ther Adv Med Oncol Letter to the Editor SAGE Publications 2023-03-17 /pmc/articles/PMC10028620/ /pubmed/36960320 http://dx.doi.org/10.1177/17588359231156383 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Sorscher, Steven Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis |
| title | Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| title_full | Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| title_fullStr | Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| title_full_unstemmed | Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| title_short | Why the length of recurrence-free survival or ‘lead-times’ can be
misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et
al. Circulating DNA in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| title_sort | why the length of recurrence-free survival or ‘lead-times’ can be
misleading. comment on: callesen lb, takacova t, hamfjord j, et
al. circulating dna in patients undergoing loco-regional treatment
of colorectal cancer metastases: a systematic review and
meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028620/ https://www.ncbi.nlm.nih.gov/pubmed/36960320 http://dx.doi.org/10.1177/17588359231156383 |
| work_keys_str_mv | AT sorschersteven whythelengthofrecurrencefreesurvivalorleadtimescanbemisleadingcommentoncallesenlbtakacovathamfjordjetalcirculatingdnainpatientsundergoinglocoregionaltreatmentofcolorectalcancermetastasesasystematicreviewandmetaanalysis |